Laurus Labs Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Laurus Labs Ltd. on BSE

Load latest

Laurus Labs Ltd.

02 Aug 2019

586.75

-3.92%

Result

Laurus Labs Ltd - 540222 - Laurus Labs Unaudited Financial Results For The Quarter Ended June …

BSE India

Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Unaudited Financial Results of the Company for the Quarter ended June 30, 2019 as approved by the Board of Directors of the Company in their Meeting held on August 2, 2019 along with the Limited Review Report issued by the Statutory Auditors of the Company. The financial results are also being uploaded on the website of the Company at www.lauruslabs.com. This is for your information and records.

pdf

Laurus Labs Ltd.

30 Jul 2019

586.75

-3.92%

Company Update

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Laurus Labs Limited will organize a conference call for Investors and Analysts, on Monday, August 05, 2019 at 11:00 am IST. The conference call will be initiated with a brief management discussion on the Q1 FY20 results which will be declared on August 2, 2019. This will be followed by an interactive Question & Answer session. The call will be hosted by Kotak Institutional Equities.

pdf

Laurus Labs Ltd.

24 Jul 2019

586.75

-3.92%

Board Meeting

Laurus Labs Ltd - 540222 - Board Meeting Intimation for Intimation Of Board Meeting To Consider …

BSE India

Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Friday, August 02, 2019, inter-alia, to consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30, 2019. Further, the Company's trading window for dealing in securities by the Directors and Designated Persons has been closed from Monday, July 01, 2019, which was already intimated on June 29, 2019, and shall continue to remain closed till Sunday, August 04, 2019 (both days inclusive). This is for your information and records.

pdf

Laurus Labs Ltd.

22 Jul 2019

586.75

-3.92%

Company Update

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Laurus Labs is pleased to announce the launch of the generic version of Lyrica(r), (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg) in US market along with its exclusive distribution partner Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company. Rising recently received the final approval from the U.S. Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA). A press release to this extent is also attached for your information and records.

pdf

Laurus Labs Ltd.

18 Jul 2019

586.75

-3.92%

Company Update

Laurus Labs Ltd - 540222 - Shareholding for the Period Ended June 30, 2019

BSE India

Laurus Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here

Laurus Labs Ltd.

13 Jul 2019

586.75

-3.92%

AGM

Laurus Labs Ltd - 540222 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Laurus Labs Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

Laurus Labs Ltd.

12 Jul 2019

586.75

-3.92%

AGM

Laurus Labs Ltd - 540222 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the summary of the 14th Annual General Meeting proceedings is enclosed

pdf

Laurus Labs Ltd.

12 Jul 2019

586.75

-3.92%

AGM

Laurus Labs Ltd - 540222 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - 'SEBI (LODR) Regulations', this is to inform you that the Members of the Company transacted the business as stated in the Notice of 14th AGM dated May 2, 2019

pdf

Laurus Labs Ltd.

12 Jul 2019

586.75

-3.92%

Company Update

Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

The Company is pleased to announce that it has completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam, Andhra Pradesh, without any observations and no form 483 issued.

pdf

Laurus Labs Ltd.

08 Jul 2019, 06:02PM

586.75

-3.92%

Corp. Note

Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 and based on the certificates received from Karvy Fintech Private Limited (Registrar and Share Transfer Agent), we hereby confirm that for the quarter ended June 30, 2019, the certificates of equity shares received for dematerialization have been mutilated and cancelled only after due verification and that the name of the respective depository has been substituted as the registered owner in respect of those dematerialized equity shares. We further confirm that the securities comprised in the said certificates of equity shares have been listed on BSE Limited and the National Stock Exchange of India Limited where the earlier issued securities are listed.

pdf

Is Laurus Labs Ltd. worth buying?

1218 Votes:

Buy 79.56%

Sell 10.84%

Hold 9.61%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf